Analysts Viewpoint CNTA’s latest rating updates from top analysts. Centessa Pharmaceuticals plc ADR’s filing revealed that its General Counsel HUSSAIN IQBAL J unloaded Company’s shares for reported $0.1 million
Stock Earnings CNTA Stock Sees Surge of Approximately 2.68% in Last Five Days Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Analysts Viewpoint Investing in Centessa Pharmaceuticals plc ADR (CNTA) Is Getting More Attractive Centessa Pharmaceuticals plc ADR’s filing revealed that its President, Orexin Program Accardi Mario Alberto unloaded Company’s shares for reported $0.13